CLINICAL_TRIALS
withdrawal
· 2017-04-28
Clinical Trial Update: Evaluation of Patients With Idiopathic Pulmonary Fibrosis (IPF) Through an IPF Registry
Summary
The IPF registry trial NCT00212511 sponsored by NYU Langone Health has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: NYU Langone Health | Conditions: Idiopathic Pulmonary Fibrosis | Status: WITHDRAWN